Netflix: Q1 2021 Consensus Analyst Estimates

Netflix (NASDAQ: NFLX) will be reporting their first quarter financial results on April 20th after markets close. Analysts have a consensus $622.74 12-month price target on the company, via a total of 44 analysts, with 13 analysts having strong buy ratings. 20 analysts meanwhile have buy ratings, seven have hold ratings, three analysts have sell ratings and one analyst has a strong sell rating. The street high comes from Elazar Advisors with an $840 price target, and the lowest target sits at $340 from Societe Generale.

31 analysts have revenue estimates for the first quarter. The company has guided for revenues of $7.12 billion. The mean between all 31 is $7.13 billion; this number has been revised upwards from $7 billion at the start of the year. The highest revenue estimate is $7.17 billion, while the lowest is $7 billion.

Onto EBITDA estimates, there are currently 24 analysts who have first-quarter EBITDA estimates. The mean is currently $1.9 billion, with this number having been revised up from $1.5 billion at the start of the year. Street high is a $1.94 billion EBITDA estimate and the lowest estimate is currently sitting at $1.85 billion.

Analysts estimate that quarterly earnings per share will come in at $2.97, with this number being revised up from $2.08 at the start of the year. Street high is $3.02 and the lowest estimate is $2.84 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Discovery at Luis Hill Prompts Acceleration of Phase 2 Program for Questcorp

Selkirk Copper Completes 52,000 Metre Phase 1 Drill Program At Minto, Assays Pending

Related News

Else Nutrition: Canaccord Cuts Target To $2.00 After Financing

On June 22, Else Nutrition (TSX: BABY) announced that it raised $7.29 million by selling...

Monday, July 4, 2022, 04:33:00 PM

Curaleaf: Haywood Reiterates $22 Price Target, Names Firm A Top Pick For 2022

On December 28th, Curaleaf Holdings (CSE: CURA) announced that they have entered into a definitive agreement...

Friday, December 31, 2021, 04:35:00 PM

Netflix Loses Streaming Dominance As YouTube Claims Top Spot

It appears Netflix’s (Nasdaq: NFLX) reign as the top streaming platform is over, and it...

Tuesday, February 7, 2023, 09:48:19 AM

Virgin Galactic: Canaccord Slashes Price Target From $36 To $8

Last week Virgin Galactic Holdings (NYSE: SPCE) released its first quarter financial results and related...

Tuesday, May 10, 2022, 11:26:00 AM

Canaccord Raises Price Target On Alimentation Couche-Tard After Mixed Quarter

Last week, Alimentation Couche-Tard Inc. (TSX: ATD.B) reported its fiscal first quarter financial results. The...

Monday, September 6, 2021, 02:23:00 PM